BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30129248)

  • 1. Managing hypogammaglobulinaemia secondary to haematological malignancies in Australia and New Zealand: a clinician survey.
    Wong J; Wood EM; Crispin P; Weinkove R; McQuilten ZK;
    Intern Med J; 2019 Mar; 49(3):358-363. PubMed ID: 30129248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinician survey for management of the secondary immunodeficiency caused by hematological malignancies in China.
    Ye C; Liu J; Song X; Zheng S; Liu J
    Medicine (Baltimore); 2021 Jan; 100(3):e23935. PubMed ID: 33545966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation: immunoglobulin vs prophylactic antibiotics in hypogammaglobulinemia and hematological malignancies.
    Carrillo de Albornoz S; Higgins AM; Petrie D; Irving A; Fanning L; Weinkove R; Crispin P; Dendle C; Gilbertson M; Johnston A; Keegan A; Pepperell D; Pullon H; Reynolds J; van Tonder T; Trotman J; Waters N; Wellard C; Weston H; Morrissey CO; Wood EM; McQuilten ZK
    Blood Adv; 2024 May; 8(9):2259-2267. PubMed ID: 38484199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlations between secondary hypogammaglobulinaemia, infections and mortality and the need for preventive immunoglobulin replacement in patients with chronic lymphoid leukaemia].
    Losonczy H; Nagy Á; Kosztolányi S; Tóth O; Csalódi R; Hussain A; Szomor Á
    Orv Hetil; 2019 Sep; 160(38):1487-1494. PubMed ID: 31537095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin replacement vs prophylactic antibiotics for hypogammaglobulinemia secondary to hematological malignancy.
    McQuilten ZK; Weinkove R; Thao LTP; Crispin P; Degelia A; Dendle C; Gilbertson M; Johnston A; Keegan A; Pepperell D; Pullon H; Reynolds J; van Tonder T; Trotman J; Waters N; Wellard C; Weston H; Morrissey CO; Wood EM
    Blood Adv; 2024 Apr; 8(7):1787-1795. PubMed ID: 38592710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory correlates of lung disease and cancer in adults with idiopathic hypogammaglobulinaemia.
    Brent J; Guzman D; Bangs C; Grimbacher B; Fayolle C; Huissoon A; Bethune C; Thomas M; Patel S; Jolles S; Alachkar H; Kumaratne D; Baxendale H; Edgar JD; Helbert M; Hambleton S; Arkwright PD
    Clin Exp Immunol; 2016 Apr; 184(1):73-82. PubMed ID: 26646609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing Immunoglobulin Replacement Therapy for Patients with Non-classical and Secondary Antibody Deficiency: an Analysis of the Practice of Clinical Immunologists in the UK and Republic of Ireland.
    Edgar JDM; Richter AG; Huissoon AP; Kumararatne DS; Baxendale HE; Bethune CA; Garcez T; Misbah SA; Sorensen RU;
    J Clin Immunol; 2018 Feb; 38(2):204-213. PubMed ID: 29423883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoglobulin replacement therapy contribution in agammaglobulinemia: 10 case reports].
    Ksouri H; Mellouli F; Barbouch R; Ben Hassen A; Béjaoui M
    Arch Pediatr; 2006 Jul; 13(7):1034-9. PubMed ID: 16713207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin replacement therapy in chronic lymphocytic leukaemia patients with hypogammaglobulinaemia and infection.
    Keegan A; Dennington PM; Dhondy N; Mulligan SP
    Eur J Haematol; 2022 Jun; 108(6):460-468. PubMed ID: 35152500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of intravenous immunoglobulin prophylaxis for patients with chronic lymphocytic leukaemia and secondary hypogammaglobulinaemia.
    Boughton BJ; Jackson N; Lim S; Smith N
    Clin Lab Haematol; 1995 Mar; 17(1):75-80. PubMed ID: 7621634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hypogammaglobulinaemia occurring in patients with systemic lupus erythematosus.
    Yong PF; Aslam L; Karim MY; Khamashta MA
    Rheumatology (Oxford); 2008 Sep; 47(9):1400-5. PubMed ID: 18625660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial Serum Immunoglobulin G (IgG) Trough Levels in Patients with X-linked Agammaglobulinemia on Replacement Therapy with Intravenous Immunoglobulin: Its Correlation with Infections in Indian Children.
    Suri D; Bhattad S; Sharma A; Gupta A; Rawat A; Sehgal S; Singh S; Gupta S
    J Clin Immunol; 2017 Apr; 37(3):311-318. PubMed ID: 28321612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multinational Comparison of Prophylactic Antibiotic Use for Eyelid Surgery.
    Fay A; Nallasamy N; Bernardini F; Wladis EJ; Durand ML; Devoto MH; Meyer D; Hartstein M; Honavar S; Osaki MH; Osaki TH; Santiago YM; Sales-Sanz M; Vadala G; Verity D
    JAMA Ophthalmol; 2015 Jul; 133(7):778-84. PubMed ID: 25905446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Recovery After Surgery for Suspected Ovarian Malignancy: A Survey of Perioperative Practice Among Gynecologic Oncologists in Australia and New Zealand to Inform a Clinical Trial.
    Lindemann K; Kok PS; Stockler M; Sykes P; Brand A
    Int J Gynecol Cancer; 2017 Jun; 27(5):1046-1050. PubMed ID: 28525497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hypogammaglobulinaemia in chronic lymphocytic leukaemia by low-dose intravenous gammaglobulin.
    Jurlander J; Geisler CH; Hansen MM
    Eur J Haematol; 1994 Aug; 53(2):114-8. PubMed ID: 8088382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immune globulin in chronic lymphocytic leukaemia.
    Gamm H; Huber C; Chapel H; Lee M; Ries F; Dicato MA
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):17-20. PubMed ID: 8033428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hypogammaglobulinaemia with intravenous immunoglobulin, 1973-93.
    Skull S; Kemp A
    Arch Dis Child; 1996 Jun; 74(6):527-30. PubMed ID: 8758130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogammaglobulinaemia in low grade B cell tumours; significance and therapy.
    Chapel H; Griffiths H; Brennan V; Bunch C; Lea J; Lee M
    Immunol Invest; 1991 Apr; 20(2):187-91. PubMed ID: 1864637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilisation of immunoglobulin in New Zealand.
    Mishra S; Flanagan P; Frampton C
    Intern Med J; 2023 Jun; 53(6):1032-1041. PubMed ID: 35049107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis.
    Besada E; Koldingsnes W; Nossent JC
    Rheumatology (Oxford); 2014 Oct; 53(10):1818-24. PubMed ID: 24831059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.